undefined undefined
NaN.000
NaN.00%
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
05-09 00:00
Day One Biopharmaceuticals press release (NASDAQ:DAWN): Q1 GAAP EPS of -$0.72 misses by $0.06. Cash, cash equivalents and short-term investments totaled $317.9M on March 31, 2024. Believes it has suff...
05-07 05:55
Day One Biopharmaceuticals (DAWN) just unveiled an announcement. On May 6, 2024...
05-07 04:43
Day One Biopharmaceutical (NASDAQ:DAWN) reported quarterly losses of $(0.72) pe...
05-07 04:33
The U.S. Food and Drug Administration (FDA) on Tuesday greenlighted Day One Biopharmaceuticals’ (NASDAQ:DAWN) lead candidate tovorafenib for a type of pediatric brain cancer called low-grade glioma. A...
04-24 01:59
小摩:维持Day One Biopharmaceutical(DAWN.US)评级,由增持调整至增持评级, 目标价由32.00美元调整至36.00美元。
04-22 22:31
Oppenheimer analyst Matthew Biegler reiterates Day One Biopharmaceutical (NASDAQ:DAWN) from Perform to Perform.
02-27 20:36
Meiragtx获得赛诺菲 3000万美元战略投资,股价大涨超20%;DCPH宣布 Vimseltinib 3期研究取得积极结果,隔夜涨超17%>>
2023-10-31 18:39
U.S. stocks traded higher, with the Nasdaq Composite gaining more than 100 points on Monday. Here are some big stocks recording gains in today’s session.
2023-10-30 22:19